HYPERFINE INC (HYPR) Fundamental Analysis & Valuation

NASDAQ:HYPR • US44916K1060

1.16 USD
0 (0%)
At close: Mar 10, 2026
1.18 USD
+0.02 (+1.72%)
After Hours: 3/10/2026, 6:13:27 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HYPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

HYPR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While HYPR seems to be doing ok healthwise, there are quite some concerns on its profitability. HYPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. HYPR Profitability Analysis

1.1 Basic Checks

  • HYPR had negative earnings in the past year.
  • HYPR had a negative operating cash flow in the past year.
  • HYPR had negative earnings in each of the past 5 years.
  • HYPR had a negative operating cash flow in each of the past 5 years.
HYPR Yearly Net Income VS EBIT VS OCF VS FCFHYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • HYPR has a Return On Assets of -96.49%. This is in the lower half of the industry: HYPR underperforms 79.89% of its industry peers.
  • HYPR has a Return On Equity of -149.05%. This is in the lower half of the industry: HYPR underperforms 69.02% of its industry peers.
Industry RankSector Rank
ROA -96.49%
ROE -149.05%
ROIC N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
HYPR Yearly ROA, ROE, ROICHYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 46.12%, HYPR is doing worse than 60.33% of the companies in the same industry.
  • HYPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPR Yearly Profit, Operating, Gross MarginsHYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HYPR Health Analysis

2.1 Basic Checks

  • HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HYPR has been increased compared to 1 year ago.
  • There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HYPR Yearly Shares OutstandingHYPR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
HYPR Yearly Total Debt VS Total AssetsHYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • HYPR has an Altman-Z score of -8.31. This is a bad value and indicates that HYPR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HYPR (-8.31) is worse than 76.63% of its industry peers.
  • There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.31
ROIC/WACCN/A
WACC9.87%
HYPR Yearly LT Debt VS Equity VS FCFHYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 3.63 indicates that HYPR has no problem at all paying its short term obligations.
  • The Current ratio of HYPR (3.63) is better than 61.96% of its industry peers.
  • A Quick Ratio of 3.06 indicates that HYPR has no problem at all paying its short term obligations.
  • The Quick ratio of HYPR (3.06) is better than 65.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.06
HYPR Yearly Current Assets VS Current LiabilitesHYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. HYPR Growth Analysis

3.1 Past

  • HYPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.53%, which is quite good.
  • HYPR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.10%.
  • Measured over the past years, HYPR shows a very strong growth in Revenue. The Revenue has been growing by 105.01% on average per year.
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)-20.1%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-5.65%

3.2 Future

  • HYPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
  • The Revenue is expected to grow by 16.76% on average over the next years. This is quite good.
EPS Next Y17.13%
EPS Next 2Y16.73%
EPS Next 3Y8.85%
EPS Next 5Y8.04%
Revenue Next Year-1.18%
Revenue Next 2Y15.26%
Revenue Next 3Y16.27%
Revenue Next 5Y16.76%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HYPR Yearly Revenue VS EstimatesHYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5M 10M 15M 20M 25M
HYPR Yearly EPS VS EstimatesHYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. HYPR Valuation Analysis

4.1 Price/Earnings Ratio

  • HYPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HYPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPR Price Earnings VS Forward Price EarningsHYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPR Per share dataHYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.73%
EPS Next 3Y8.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HYPR Dividend Analysis

5.1 Amount

  • No dividends for HYPR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HYPR Fundamentals: All Metrics, Ratios and Statistics

HYPERFINE INC

NASDAQ:HYPR (3/10/2026, 6:13:27 PM)

After market: 1.18 +0.02 (+1.72%)

1.16

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-18
Inst Owners16.23%
Inst Owner Change38.93%
Ins Owners1.34%
Ins Owner Change-0.08%
Market Cap116.73M
Revenue(TTM)10.59M
Net Income(TTM)-40.05M
Analysts82.5
Price Target1.68 (44.83%)
Short Float %1.67%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.37%
Min EPS beat(2)-2.71%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-4.81%
Min EPS beat(4)-16.81%
Max EPS beat(4)1.96%
EPS beat(8)5
Avg EPS beat(8)1.18%
EPS beat(12)8
Avg EPS beat(12)1.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.25%
Min Revenue beat(2)-11.9%
Max Revenue beat(2)-2.61%
Revenue beat(4)0
Avg Revenue beat(4)-16.05%
Min Revenue beat(4)-25.57%
Max Revenue beat(4)-2.61%
Revenue beat(8)3
Avg Revenue beat(8)-8.75%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.02
P/FCF N/A
P/OCF N/A
P/B 4.34
P/tB 4.34
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.11
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -96.49%
ROE -149.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.12%
FCFM N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 108.34%
Cap/Sales 10.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.06
Altman-Z -8.31
F-Score4
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)57.29%
Cap/Depr(5y)217.57%
Cap/Sales(3y)6.28%
Cap/Sales(5y)146.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y17.13%
EPS Next 2Y16.73%
EPS Next 3Y8.85%
EPS Next 5Y8.04%
Revenue 1Y (TTM)-20.1%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-5.65%
Revenue Next Year-1.18%
Revenue Next 2Y15.26%
Revenue Next 3Y16.27%
Revenue Next 5Y16.76%
EBIT growth 1Y8.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.22%
EBIT Next 3Y11.71%
EBIT Next 5YN/A
FCF growth 1Y8.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.28%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERFINE INC / HYPR FAQ

What is the fundamental rating for HYPR stock?

ChartMill assigns a fundamental rating of 3 / 10 to HYPR.


What is the valuation status of HYPERFINE INC (HYPR) stock?

ChartMill assigns a valuation rating of 0 / 10 to HYPERFINE INC (HYPR). This can be considered as Overvalued.


What is the profitability of HYPR stock?

HYPERFINE INC (HYPR) has a profitability rating of 0 / 10.